For a Spokane allergy practice, the most dangerous claims are not the shots — they are the biologics for severe asthma and chronic urticaria. A single dose can run $30,000 a year, and whether it pays comes down to three facts that have to be right before the drug ever reaches the patient: verification of benefits confirming the drug is covered, a prior authorization on file, and correct benefit routing between the medical and pharmacy lane. Get any one wrong and the practice eats the cost of a drug it already bought and administered. In a rural referral market, where a patient may drive two hours for an infusion, a same-day cancellation because an auth was not confirmed is not just a lost slot — it is a delayed therapy and an angry referral source.
Verification is equally decisive on the immunotherapy side. Apple Health coverage churns month to month, so a patient active at the last shot visit can be retroactively terminated by the next, and a build-up series billed against lapsed coverage becomes an uncollectable write-off. Benefit routing shifts across the Apple Health MCOs — Amerigroup, Community Health Plan of Washington, Coordinated Care, Molina, and UnitedHealthcare Community Plan — while Noridian carries Part B for Washington's large Medicare panel. A professional, allergy-specific billing partner treats verification and prior authorization as the front end of the revenue cycle, not an afterthought, because in Spokane that front end is where the money is won or lost.
The cross-border reality adds a wrinkle unique to this market. Spokane routinely treats patients from northern Idaho, and a patient who lives across the state line but works in Washington — or the reverse — can carry a plan with out-of-network rules, different prior-authorization vendors, and its own timely-filing deadlines. Coordination of benefits between a primary and secondary payer has to be sorted before a biologic is scheduled, not discovered when the remit posts at a fraction of the expected amount. These are not clinical problems; they are revenue-cycle problems, and they are precisely the ones a busy Spokane front desk cannot chase down while also rooming patients and managing infusion logistics.